Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers.
PMID:35903525
Comparison of Drug Withdrawal Processes in the U.S. and Other Nations.
PMID:35601589
Long-Term Electrical and Mechanical Function Monitoring of a Human-on-a-Chip System.
PMID:35586798
An Explainable Supervised Machine Learning Model for Predicting Respiratory Toxicity of Chemicals Using Optimal Molecular Descriptors.
PMID:35456666
Simultaneous triple-parametric optical mapping of transmembrane potential, intracellular calcium and NADH for cardiac physiology assessment.
PMID:35388167
High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition.
PMID:35205076
Essential oil from Cymbopogon citratus exhibits "anti-aspergillosis" potential: in-silico molecular docking and in vitro studies.
PMID:35125860
Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies.
PMID:35024565
Zebrafish Embryos and Larvae as Alternative Animal Models for Toxicity Testing.
PMID:34948215
DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology.
PMID:34772471
Path4Drug: Data Science Workflow for Identification of Tissue-Specific Biological Pathways Modulated by Toxic Drugs.
PMID:34721010
Blood Neurofilament Light Chain as a Potential Biomarker for Central and Peripheral Nervous Toxicity in Rats.
PMID:34677616
Impacts of diphenylamine NSAID halogenation on bioactivation risks.
PMID:34107285
Assessing Consistency Across Functional Screening Datasets in Cancer Cells.
PMID:34081116
Engineering Cardiovascular Tissue Chips for Disease Modeling and Drug Screening Applications.
PMID:33959600
The Promise of AI for DILI Prediction.
PMID:33937745
Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity.
PMID:33790786
A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.
PMID:33732695
Chemical Aspects of Human and Environmental Overload with Fluorine.
PMID:33723999
Zebrafish: An emerging whole-organism screening tool in safety pharmacology.
PMID:33666192
Combining In Vivo Data with In Silico Predictions for Modeling Hepatic Steatosis by Using Stratified Bagging and Conformal Prediction.
PMID:33347274
Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles.
PMID:33338435
Human biomimetic liver microphysiology systems in drug development and precision medicine.
PMID:33335282
Network integration and modelling of dynamic drug responses at multi-omics levels.
PMID:33060801
From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery.
PMID:32848750
From Human Pluripotent Stem Cells to 3D Cardiac Microtissues: Progress, Applications and Challenges.
PMID:32785039
In silico prediction of chemical neurotoxicity using machine learning.
PMID:32670548
h-FIBER: Microfluidic Topographical Hollow Fiber for Studies of Glomerular Filtration Barrier.
PMID:32607437
Nanotoxicology and Nanosafety: Safety-By-Design and Testing at a Glance.
PMID:32605255
One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility.
PMID:32464151
Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.
PMID:32447523
Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
PMID:32422053
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Part 2: Potential Alternatives to the Use of Animals in Preclinical Trials.
PMID:32363250
Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications.
PMID:32283585
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?
PMID:31998852
In silico analysis of alternative splicing on drug-target gene interactions.
PMID:31924844
Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials.
PMID:31480618
Engineered Cardiac Tissues Generated in the Biowire™ II: A Platform for Human-Based Drug Discovery.
PMID:31385592
Comparison of zebrafish larvae and hiPSC cardiomyocytes for predicting drug induced cardiotoxicity in humans.
PMID:31359052
Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis.
PMID:31349548
Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.
PMID:31295521
ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness.
PMID:30774861
A Comprehensive Map of FDA-Approved Pharmaceutical Products.
PMID:30563197
Comparison of Quantitative and Qualitative (Q)SAR Models Created for the Prediction of Ki and IC50 Values of Antitarget Inhibitors.
PMID:30364128
Cardiovascular disease models: A game changing paradigm in drug discovery and screening.
PMID:30343824
Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach.
PMID:30342048
Topological alternate centrality measure capturing drug targets in the network of MAPK pathways.
PMID:30259868
Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.
PMID:30130706
A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents.
PMID:30103549
Intact Cell Lipidomics Reveal Changes to the Ratio of Cardiolipins to Phosphatidylinositols in Response to Kanamycin in HeLa and Primary Cells.
PMID:29947513
ProTox-II: a webserver for the prediction of toxicity of chemicals.
PMID:29718510
Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity.
PMID:29620051
Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.
PMID:29362275
Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?
PMID:29163223
SuperDRUG2: a one stop resource for approved/marketed drugs.
PMID:29140469
Self-contained, low-cost Body-on-a-Chip systems for drug development.
PMID:29065797
Natural products modulating the hERG channel: heartaches and hope.
PMID:28497823
Mouse Models for Drug Discovery. Can New Tools and Technology Improve Translational Power?
PMID:28053071
The ChEMBL database in 2017.
PMID:27899562
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
PMID:27641943
A k-nearest neighbor classification of hERG K(+) channel blockers.
PMID:26860111
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature.
PMID:26843061
The 2016 database issue of Nucleic Acids Research and an updated molecular biology database collection.
PMID:26740669